2-203252041-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000356079.9(CYP20A1):āc.364A>Gā(p.Met122Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000256 in 1,611,768 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000356079.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP20A1 | NM_177538.3 | c.364A>G | p.Met122Val | missense_variant | 4/13 | ENST00000356079.9 | NP_803882.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP20A1 | ENST00000356079.9 | c.364A>G | p.Met122Val | missense_variant | 4/13 | 1 | NM_177538.3 | ENSP00000348380 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000409 AC: 62AN: 151506Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.000447 AC: 112AN: 250352Hom.: 0 AF XY: 0.000443 AC XY: 60AN XY: 135370
GnomAD4 exome AF: 0.000240 AC: 351AN: 1460144Hom.: 2 Cov.: 32 AF XY: 0.000264 AC XY: 192AN XY: 726430
GnomAD4 genome AF: 0.000409 AC: 62AN: 151624Hom.: 0 Cov.: 27 AF XY: 0.000419 AC XY: 31AN XY: 74064
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.364A>G (p.M122V) alteration is located in exon 4 (coding exon 4) of the CYP20A1 gene. This alteration results from a A to G substitution at nucleotide position 364, causing the methionine (M) at amino acid position 122 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at